re: basic pharmacokinetics dank
So Dank, from your findings, if GSK don,t get a riggle on, which I think they are doing, Peramivir could be a likely contender for the antiviral market, with Relenza?
BTA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held